Skip to content
OpenCapital
Get started

International Flavors & Fragrances IFF Health & Biosciences — Segment Adjusted Operating EBITDA

Similar metrics at other companies

IDEX logo
IEXHealth & Science Technologies — Segment Adjusted EBITDA
$106M+21.3%
Clarivate logo
CLVTLife Sciences & Healthcare — Adjusted EBITDA
$29.2M-4.6%
Clorox logo
CLXHealth and Wellness — Segment Adjusted EBIT
$158M-6.5%
SelectQuote logo
SLQTHealthcare Services — Adjusted Segment EBITDA
$5.28M-18.1%
Radiant Logistics logo
RLGTSegment Adjusted Ebitda
$10.58M-12.7%
AdaptHealth logo
AHCODiabetes Health — Adjusted EBITDA
$4.14M-35.2%

Other financials

Income statement

See full
Revenue$2.7B-3.6%
Gross profit$1.0B-1.6%
Operating income$273.0M+130%
Net income$169.0M+117%
EPS (diluted)$0.66+117%

Balance sheet

See full
Cash & equivalents$562.0M-13.5%
Total debt$6.3B-35.5%
Total equity$14.1B+7.2%
Total assets$25.1B-11.0%

Cash flow

See full
Operating cash flow$257.0M+102%
CapEx$165.0M-7.8%
Free cash flow$92.0M+277%

Valuation

See full
Market cap$19.23B-1.9%
Enterprise value$25.01B-2.1%
P/E23.4×—
P/S1.8×0.0×

Profitability

See full
Gross margin36.3%+0.2pp
Operating margin-3.2%-1.4pp
Net margin7.6%+5.2pp
FCF margin3.7%-1.3pp

Returns & leverage

See full
Return on equity6%+4.0pp
Debt / equity0.4×-0.3×
Current ratio1.5×-0.4×

Where this comes from

Reported directly by International Flavors & Fragrances in its filing.

Tagged under the XBRL concept iff:SegmentAdjustedOperatingEBITDA.

The official record: International Flavors & Fragrances’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about International Flavors & Fragrances's health & biosciences — segment adjusted operating ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is International Flavors & Fragrances's health & biosciences — segment adjusted operating EBITDA?
International Flavors & Fragrances (IFF) reported health & biosciences — segment adjusted operating EBITDA of $153M in Q1 2026.
How has International Flavors & Fragrances's health & biosciences — segment adjusted operating EBITDA changed year-over-year?
International Flavors & Fragrances's health & biosciences — segment adjusted operating EBITDA increased by 10.9% year-over-year, from $138M to $153M.
What is the long-term trend for International Flavors & Fragrances's health & biosciences — segment adjusted operating EBITDA?
Over 3 years (2022 to 2025), International Flavors & Fragrances's health & biosciences — segment adjusted operating EBITDA has grown at a -2.1% compound annual growth rate (CAGR), from $634M to $594M.
What does health & biosciences — segment adjusted operating EBITDA mean?
A measure of the Health & Biosciences segment's operating profitability, excluding interest, taxes, depreciation, amortization, and non-recurring items. It provides a view of the segment's core cash-generating capability before capital structure and accounting adjustments.